News
Videos
Conferences
Events
Resources
Subscribe

|Articles|October 1, 2015

Aziz Nazha Discusses the Future of Treating Patients With MDS

Author(s)Aziz Nazha

Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses the future of treating patients with myelodysplastic syndrome (MDS).

Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses the future of treating patients with myelodysplastic syndrome (MDS).

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Trending on CURE

Basal Cell Carcinoma Basics, From Diagnosis to Treatment

Brachytherapy, Chemo, and Turner Syndrome: A Teen's Rare Cancer Battle

FDA Grants Orphan Drug Designation to M2T-CD33 in AML

HR+/HER2– Breast Cancer: Diagnosis and Treatment Guide

Covering Every FDA Oncology Approval From October 2025

© 2025 MJH Life Sciences^®

All rights reserved.